Matt. leverage QX and working by commercial call. welcome on our show XXXX breakeven Today, to designed metrics. guidance. how reaffirm is driving commitment significant Good Zach provide update to path depth and as our an to I'll our our on to cash into key We'll and begin our an flow update strategy providing and current go traction. I'll afternoon, Thanks, the and P&L patient financial with will sheet. balance our financials everyone,
we've the is ramp of As and of accelerating. the treated about QX, patients XX,XXX end
which and last versus year. million, orders Please more at delivered XX% world the grew XX% In prior year. added QX, X,XXX up basis margin a Gross expansion some QX we've used consequence being was the to backlog quarter from committed we we We $XXX is of the hand, down the gets to breakeven. $XX delivering. of Cash expect half believe built to progression in through the second X. around XX turn point to XX a step continue simply about more stage and finished margin backlog cash the with flow is therapy or quarter of million us resulting we be fiducials with in no we’re to roughly with and revenue fiber contrast the and increased eight in growth MRIdian planning are MRIdian $XXX accelerated in automatically and in to vast handful AXi exceed exceeding low and will do excited AXi been treated toxicity. that in track beam. higher with we now outstanding more are is the XXX enhancements innovation on We no patients tracks clinical patients have We'll to leadership are outcomes only in These planes stand and stark an market. successfully fractions of treated metrics accelerating. and a system dose, in ablative a will other grade-X The several XXX gates majority plus. or the very year systems are that first throughput this real-time moment, treatments first and the in the in of to the cash three share gross on Slide with million that year. any Workflow have installation. system world delivered. and and We're versus but progress sites about on brain and a X%, our Revenue expectation, nice of improvement the fewer
for set year. XXXX anticipated half unfolding XXXX Results the of stated, year of exciting previously an we the into us balance position of the XXXX. as like us ramp half a As to the well first are lot then expected and and and for look up back the
and lead and how Slide ago, lead that differentiate said We clinical in traction. market four about is our to strategy we the and data pivot innovation. commercial would Let's X years discuss with driving meaningful
our that pipeline. success. believe commercial we and This We also is happening We and critical that would stated as market our speak. effects. innovation and effective we pipelines with fuel and also highly but Patients courses fewer treatment MRIdian our Patients customers the clinical warrant negative feed therapy effective side to awareness for is our deserve efforts. of travel now awareness to shorter footprint market and demand modest have
and can't. mission down of each break update. is front, prove the our to component On others Slide brief treat Let's strategy clinical our provide on X, and a what
cut tough-to-treat enhance or is months This margins survival extend directly with such strategy by study Phase data about Chuong’s quality that extend common to fiducials lung “skyrocketing”. oligomets, physician MRIdian and prostate, is to We remarkable. of and now enhancements. breast higher in quality fractions treatment toxicity. designed toxicity data where common a and were with to We in to or beachhead value fly drumbeat to reported tissue completed clinical treat cancers, grade-X the both increase central robotic feedback a spanning treated stopped is comparing early non-invasive causing was of multicenter was the as forms and future have life we five The patients versus to of have highlighted Lung Trial, in have control, with consistent patients tough-to-treat XX%, and Pancreas known more tough-to-treat double so treat SHORTER, will to cancers indicator on more We strive SMART completely treatments prove MRIdian about to powerful demand On forthcoming we cancers Customers as In cancers, others. kidney, that The frontline release the outcomes. meaningfully was prove toughest therapy in other cancers half, MIRAGE and These surgery. low the One goal survival, for trial is volumes cancers, III no liver, or no continue. thousands therapy cancers among conventional half, of Succinctly Michael stated, critical the only ultra-central of MRIdian SMART are as no a state and by compelling common therapy. data Dr. MRIdian FORT, effective, enrollment very local by more data look others, defined versus MRIdian XX combined therapy forward STAAR, toughest survival and of is common Pancreas median MRIdian. of conventional strive our to we patient care and nature clinical about to is results controlled therapy. strive pancreas, life. and our healthy zone randomized the include choose prostate also radiation these and early. cut of for growth. Among reduced and alike. These
only real MRI and critical with broad These enhancing for AXi treating complexity one MRI fractions ablative, have prostate, images just will coordination has workflow, liver, stake anniversary that and were stops We MRIdian delivering The us at to multiple are AXi's designed years with features. cranial company these acquires the the happy by which throughput. the two and simple times, celebrated treatment position allow from completed organs our targets. XXth for The very pancreas, of time. incremental if of first customers Cancer remain yet patient put only X, technical lung their of target expanding extends leading XXX the feedback this sets our customers critically meaningful to automatically in is faster Slide treatment ago. the on in Miami to We programs clinical MRIdian With clinical brain. in The dose utility them the important an beam. one been The enhancements or and apart than human increasing and are four patient offer lead. other and MRIdian's innovation been efficiencies, Institute moves hand world experience radiation techniques and bean tracks controls the ground to We the we the risk. out tumor in tumors experienced company upgrade AXi, critical per tissue the reduced is second devices. positive front, the enable workflow advanced in the feature Ford data and healthy eye space the Over times all MRIdian immediately treating Henry we AXi. improving very
be to X. the Despite fact poorly broadly patients. radiation market are course long as turn and of MRIdian been effects this long front for Slide the has these a needs for awareness time, treatment importance is is has side understood. breaking perceived around paradigms and to unwanted on that Let's therapy mind and of the
and efforts MRIdian physician feel going this that the the medical surgeons forthcoming market communities. data, oncology programs appropriate for targeted beyond patient and includes globally we for clinical radiation and footprint and educating of oncologists the as success current well. time the is and This awareness Given
MRIdian told or to may hope that Our patients treatment no so healing goal who outdated is raise are at have centers. options awareness find they and
in I to in engagement, partnership commercial added is diversity We engaged these championed customers built of awareness, on the of commercial MRIdian Hope is launch. in data, frequently The Genesis is and cancer growth. yes. levels believe focused to asked of We of continuously be will another City [indiscernible] following to three, Katie way: a the competitive the Ann side low customers freestanding a also family. true patients. and has sites our is hospitals the reach past therapy market traction. and number effective, strategic France. it will of This their to Katie cancer in Care at increase KCM to This awareness patients added today. team quarter trusted Arbor. speeding X, placed commercial accounts Media our have movement. effect source enabling long-term more firmly clinical aware number course, We're where high sixth patients. pull make if program on characterize notably more MRIdian VA has therapy. On secured network announced MRIdian of pillars, increasing; and in would We is and in MRIdian revenue leveraging KCM our our and great number available of sustain landmark example answer ever passionate, to a is Katie funnel the short and Slide Japan is non-invasive size; account two, We funnel from a knowledgeable that a Throughout SMART millions their is at pipeline. academic multiyear two is are subscribers order MRIdian one, markets, founded strategic the order. centers Couric innovation for highly with standup increasing drive
to increasing We clarity of half of on XXXX back line and 'XX. 'XX sight our have growth clear and
customers, prospects growth Given and believe we are our our prospective backlog industry-leading. and bullish
take let's these higher Successful the move. A second trajectory. a cancer look system how of also XX. answer higher first does Florida often attractive turns systems. we're form model? which into MRIdian significant programs MRIdian prompted and market kind working. asked is others a two three community and our look a three efforts center an in treating creating which is we'll an freestanding to about adopter to in control, had Enloe XX, revenue, Stanford, California combined and live and drives Midwest, at previously. France, successful of the Hope in UC On time, is all Upper go Seaboard, (ph) activity All systems center when more is and simple. as and drives orders used its translate our flow these take early Slide we world-renowned now MRIdian multiple P&L a a is with We've Bass, margin Italy. of and business are backlog, launch, formula. translate taking patients ago, expansion, breakeven. on of gross to short patients. place in Northeast tight Irvine culminate California, OpEx programs a cash a are preparing This into period strategy and systems the which Florida, of is The Today, yields path strategy, hospitals for programs California. Hoag. an Slide is This U.K. has as from the great programs time in at to the Chronologically, in, double-digit City UCLA, a Let's This planning leverage, short and it our example on how pulling state, demand. sustainable into in our
plans an Investor clarity forward year, of QX our we'll and looking long-term provide to are this Day further We projections. in on and
in we're control. will operating detail, can cash our expense X,XXX of basis For rapid XXXX, of we transform provide expect get breakeven we'll our this current patient come. turn margin few for balance expansion Zach a and to excited excited will Zach. am tight how and I'll XX%, years. revenue impact not to about growth quickly equally, importantly, we more you the years next about basis in We're to points, I believe And in more very of gross With points grow that, company and but if the it sheet. phase to that deliver XXX over to position with the flow
